Published in Medical Device Law Weekly, April 9th, 2006
According to the review from The Netherlands, "Atherosclerosis is characterized by a persistent, low-grade inflammatory state in which immune cell activation is inseparably linked to plaque formation and destabilization. The T-lymphocyte in particular has emerged as a pivotal player throughout the course of atherogenesis."
"As a consequence," explained S.I. van Leuven and colleagues at the Academic Medical Center in Meibergdreef, "the concept that immune modulation is a suitable target for cardiovascular...
Want to see the full article?
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Medical Device Law Weekly
NewsRx also is available at LexisNexis, Gale, ProQuest, Factiva, Dialog, Thomson Reuters, NewsEdge, and Dow Jones.